These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12738392)

  • 61. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
    Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice.
    Taylor JM; Ziman ME; Canfield DR; Vajdy M; Solnick JV
    Microb Pathog; 2008 Jan; 44(1):20-7. PubMed ID: 17683897
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection.
    Ghasemi A; Mohammad N; Mautner J; Taghipour Karsabet M; Amani J; Ardjmand A; Vakili Z
    Vaccine; 2018 Aug; 36(34):5124-5132. PubMed ID: 30041879
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protection of BALB/c mice against experimental Helicobacter pylori infection by oral immunisation with H pylori heparan sulphate-binding proteins coupled to cholera toxin beta-subunit.
    Ruiz-Bustos E; Sierra-Beltran A; Romero MJ; Rodriguez-Jaramillo C; Ascencio F
    J Med Microbiol; 2000 Jun; 49(6):535-541. PubMed ID: 10847207
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The role of local immune response in gastric mucosa in the protection induced by Helicobacter pylori vaccine with chitosan as adjuvant].
    Xie Y; Gong YF; Zhou NJ; Chen J; Zhou XJ; Lü NH; Wang CW
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2629-35. PubMed ID: 16321324
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The rOmp22-HpaA fusion protein confers protective immunity against helicobacter pylori in mice.
    Huang X; Xu B; Duan G; Song C
    Curr Microbiol; 2013 Oct; 67(4):487-92. PubMed ID: 23715666
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
    Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of immune responses to gonococcal PorB delivered as outer membrane vesicles, recombinant protein, or Venezuelan equine encephalitis virus replicon particles.
    Zhu W; Thomas CE; Chen CJ; Van Dam CN; Johnston RE; Davis NL; Sparling PF
    Infect Immun; 2005 Nov; 73(11):7558-68. PubMed ID: 16239559
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Orally-administered outer-membrane vesicles from Helicobacter pylori reduce H. pylori infection via Th2-biased immune responses in mice.
    Liu Q; Li X; Zhang Y; Song Z; Li R; Ruan H; Huang X
    Pathog Dis; 2019 Jul; 77(5):. PubMed ID: 31504509
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies.
    Sutton P; Wilson J; Kosaka T; Wolowczuk I; Lee A
    Immunol Cell Biol; 2000 Feb; 78(1):28-30. PubMed ID: 10651926
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.
    Malfertheiner P; Schultze V; Rosenkranz B; Kaufmann SH; Ulrichs T; Novicki D; Norelli F; Contorni M; Peppoloni S; Berti D; Tornese D; Ganju J; Palla E; Rappuoli R; Scharschmidt BF; Del Giudice G
    Gastroenterology; 2008 Sep; 135(3):787-95. PubMed ID: 18619971
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A food-grade engineered Lactococcus lactis strain delivering Helicobacter pylori Lpp20 alleviates bacterial infection in H. pylori-challenged mice.
    Sun N; Zhang R; Duan G; Peng X; Wang C; Chen S; Fan Q
    Biotechnol Lett; 2019 Dec; 41(12):1415-1421. PubMed ID: 31620902
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations.
    Taylor JM; Ziman ME; Fong J; Solnick JV; Vajdy M
    Infect Immun; 2007 Jul; 75(7):3462-9. PubMed ID: 17502399
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dendritic cells prevent rather than promote immunity conferred by a helicobacter vaccine using a mycobacterial adjuvant.
    Hitzler I; Oertli M; Becher B; Agger EM; Müller A
    Gastroenterology; 2011 Jul; 141(1):186-96, 196.e1. PubMed ID: 21569773
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.
    Weltzin R; Kleanthous H; Guirakhoo F; Monath TP; Lee CK
    Vaccine; 1997 Mar; 15(4):370-6. PubMed ID: 9141207
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine.
    Gong Y; Tao L; Wang F; Liu W; Jing L; Liu D; Hu S; Xie Y; Zhou N
    Mol Med Rep; 2015 Sep; 12(3):4123-4132. PubMed ID: 26095723
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessment of outer membrane vesicles of periodontopathic bacterium Porphyromonas gingivalis as possible mucosal immunogen.
    Nakao R; Hasegawa H; Dongying B; Ohnishi M; Senpuku H
    Vaccine; 2016 Aug; 34(38):4626-4634. PubMed ID: 27461458
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum-derived IgG1-mediated immune exclusion as a mechanism of protection against H. pylori infection.
    Keenan J; Neal S; Allardyce R; Roake J
    Vaccine; 2002 Jul; 20(23-24):2981-8. PubMed ID: 12126911
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunoinformatics Approach to Design a Novel Epitope-Based Oral Vaccine Against
    Urrutia-Baca VH; Gomez-Flores R; De La Garza-Ramos MA; Tamez-Guerra P; Lucio-Sauceda DG; Rodríguez-Padilla MC
    J Comput Biol; 2019 Oct; 26(10):1177-1190. PubMed ID: 31120321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.